Foretinib GSK 1363089 - Exel 2880 - XL 880
Biological Activity:
An orally available inhibitor targeting c-MET (IC50: 0.4 nM), VEGFR and AXL.
References: online
JP Eder et al. A Phase I Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Early Antitumor Activity of Foretinib. Clin. Cancer Res. 2010, 16(13), 3507. [online]
L Liu et al. Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL. Cancer Res. 2009, 69(17), 6871-8. [online]
Chemical Name: N-[3-fluoro-4-({6-methoxy-7-[3-(morpholin-4-yl)propoxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
单位名称: |
详细地址:
北京市海淀区西三旗建材城中路12号院8号楼3单元
|
qq:
2477120690
|
联系电话: |
Email: |